Skip to main content

Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance.

Lei G, Sun M, Cheng J, Ye R, Lu Z, Horbath A, Huo D, Wu S, Alapati A, Aggarwal S, Xu Z, Mao C, Yan Y, Yao J, Li Q, Chen X, Lee H, Zhuang L, Jiang D, Pataer A, Roth JA, Navin N, Koong AC, You MJ, Lin SH, Gan B
Cancer Cell. 2025 Jun 9;43(6):1076-1092.e5. doi: 10.1016/j.ccell.2025.03.031. Epub 2025 Apr 10. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
251679lentiCRISPR v2-sgFDX1-1gRNA to knock out FDX1 in mammalian cells
251681lentiCRISPR v2-sgLIAS-1gRNA to knock out LIAS in mammalian cells
251682lentiCRISPR v2-sgLIAS-2gRNA to knock out LIAS in mammalian cells
251684lentiCRISPR v2-sgSLC11A2gRNA to knock out SLC11A2 in mammalian cells
251685lentiCRISPR v2-sgETS1-1gRNA to knock out ETS1 in mammalian cells
251686lentiCRISPR v2-sgETS1-2gRNA to knock out ETS1 in mammalian cells
251688lentiCRISPR v2-sgSLC25A39-2gRNA to knock out SLC25A39 in mammalian cells
251689lentiCRISPR v2-sgNFE2L2gRNA to knock out NFE2L2 in mammalian cells
251690lentiCRISPR v2-sgMT1E-1gRNA to knock out MT1E in mammalian cells
251691lentiCRISPR v2-sgMT1E-2gRNA to knock out MT1E in mammalian cells
251692lentiCRISPR v2-sgMT1X-1gRNA to knock out MT1X in mammalian cells
251693lentiCRISPR v2-sgMT1X-2gRNA to knock out MT1X in mammalian cells

Antibodies from Article